Circulating Cell-free Genome Atlas Study
hero image

Mapping the landscape of genomic cancer signals in the blood

The Circulating Cell-free Genome Atlas (CCGA) Study is a prospective, observational, longitudinal, study designed to characterize the landscape of genomic cancer signals in the blood of people with and without cancer. The study enrolled approximately 15,000 participants across 142 sites in the United States and Canada, and includes both people who had cancer at the time of enrollment (newly diagnosed, and not yet received treatment) and people who did not have a known cancer diagnosis. Planned follow-up for all participants is at least five years to collect clinical outcome data.

Current Status:
Closed to enrollment

The study enrolled participants who either had a diagnosis of cancer and have not yet received treatment, or are individuals without a current or prior cancer diagnosis. All participants are 20 years of age or older.

View Full Study View Full Study
Collaborators
collaborator
collaborator
collaborator
collaborator
collaborator
collaborator
collaborator
collaborator
collaborator
collaborator
collaborator
collaborator
collaborator
collaborator
collaborator
collaborator